Search results for "Eye"

showing 10 items of 2511 documents

Immunotherapies for thyroid eye disease

2019

Thyroid eye disease is a complex autoimmune disorder which causes substantial morbidity. It can result in orbital disfigurement, double vision, and visual loss. Consequently, it has a substantial negative effect on quality of life, mental health, and socioeconomic status. Most signs and symptoms of thyroid eye disease (TED) can be explained by the expansion of the orbital contents. Steroids are the mainstay of treatment in TED. However, recurrence may occur once steroids are withdrawn. Furthermore, in most cases, normal orbital anatomy is not restored, and skilled rehabilitative surgery is required to reduce disfigurement, double vision, and to preserve vision. Therefore, novel, causal, and…

Pediatricsmedicine.medical_specialtygenetic structuresEndocrinology Diabetes and Metabolismmedicine.medical_treatmentEye diseaseMEDLINE030209 endocrinology & metabolism030204 cardiovascular system & hematologyAntibodies Monoclonal Humanized03 medical and health sciences0302 clinical medicineEndocrinologyQuality of life (healthcare)Internal MedicinemedicineHumansSocioeconomic statusNutrition and Dieteticsbusiness.industryThyroidImmunotherapymedicine.diseaseDisfigurementMental healtheye diseasesGraves Ophthalmopathymedicine.anatomical_structureImmunotherapyRituximabbusinessCurrent Opinion in Endocrinology, Diabetes & Obesity
researchProduct

Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis.

2011

The mucopolysaccharidoses (MPS) are a group of rare lysosomal storage disorders characterized by the accumulation of glycosaminoglycans in several tissues and organs. This accumulation results in an array of clinical manifestations and premature death in severe cases. Ocular problems are very common in children with MPS and may involve the cornea, sclera, trabecular meshwork, retina, optic nerve and also the posterior visual pathways. The aims of this study are to give an overview of ocular problems in MPS and to provide clinical guidelines for paediatric ophthalmologists for early diagnosis and management of ocular manifestations in children with MPS. Diagnostic problems may arise in child…

Pediatricsmedicine.medical_specialtygenetic structuresEye DiseasesMucopolysaccharidosisLysosomal storage disordersDiagnostic Techniques Ophthalmological03 medical and health sciences0302 clinical medicineOphthalmologyCorneaPrescription glassesMedicineHumansChildbusiness.industryInfant Newbornnutritional and metabolic diseasesInfantGeneral MedicineMucopolysaccharidosesmedicine.diseaseeye diseases3. Good healthScleraOphthalmologyPremature deathmedicine.anatomical_structureEyeglassesChild PreschoolPractice Guidelines as Topic030221 ophthalmology & optometryOptic nerveQuality of Lifesense organsTrabecular meshworkbusiness030217 neurology & neurosurgeryActa ophthalmologica
researchProduct

Ocular Motor Paroxysmal Events in Neonates and Infants: A Review of the Literature

2021

Abstract Background Ocular paroxysmal events can accompany a variety of neurological disorders. Particularly in infants, ocular paroxysmal events often represent a diagnostic challenge. Distinguishing between epileptic and nonepileptic events or between physiological and pathologic paroxysmal events can be challenging at this age because the clinical evaluation and physical examination are often limited. Continuous polygraphic video-electroencephalography (EEG) monitoring can be helpful in these situations. Methods We review ocular paroxysmal events in newborns and infants. The aim is to improve clinical recognition of ocular paroxysmal events and provide a guide to further management. Usin…

Pediatricsmedicine.medical_specialtygenetic structuresOcular motorSocio-culturaleEpileptic phenomenaPhysical examinationNystagmusElectroencephalographyOpsoclonus.NystagmuDiagnosis DifferentialNystagmus03 medical and health sciencesEpileptic phenomena; Newborn; Nonepileptic phenomena; Nystagmus; Opsoclonus0302 clinical medicineOcular Motility DisordersDevelopmental NeuroscienceNeuroimaging030225 pediatricsmedicineHumansNonepileptic phenomenaEpilepsymedicine.diagnostic_testbusiness.industryInfant NewbornInfantMultimodal therapyElectroencephalographyOpsoclonusNewborneye diseasesNeurologyPediatrics Perinatology and Child HealthEtiologyNeurology (clinical)medicine.symptombusinessClinical evaluation030217 neurology & neurosurgery
researchProduct

Retinopathy of prematurity-current diagnosis and management

1993

Despite advances in ophthalmological care of premature infants, retinopathy of prematurity (ROP) remains a still unsolved problem for paediatricians as well as ophthalmologists. A survey of the current literature concerning drug therapy and surgical management as related to the different stages of ROP is given. The classification system for ROP according to the International Committee is presented as well as our screening policy in relation to the literature. The effectiveness in preventing severe cases of ROP and the toxicity of vitamin E supplementation in high-risk premature infants is still disputed and no recommendations can be given. Cryotherapy is recommended in symmetric cases of st…

Pediatricsmedicine.medical_specialtygenetic structuresmedicine.medical_treatmentEye diseaseVitrectomyCryotherapyCryosurgeryPharmacotherapyVitrectomymedicineHumansMass ScreeningRetinopathy of Prematuritybusiness.industryInfant NewbornRetinal detachmentRetinopathy of prematurityPrognosismedicine.diseaseeye diseasesSurgeryScleral BucklingPediatrics Perinatology and Child Healthsense organsbusinessScleral bucklingInfant PrematureRetinopathyEuropean Journal of Pediatrics
researchProduct

Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application

2020

Background:Graves’ orbitopathy (GO) is the most frequent extrathyroidal manifestation of the autoimmune Graves’ disease. GO significantly impacts quality of life and has a psycho-social morbidity. Inflammation and swelling of the orbital tissue often leads to proptosis, diplopia, and decrease of visual acuity. Due to the inflammatory background of the disease, glucocorticoids (GC) have been used as a first-line treatment for decades.Methods:PubMed and MeSH database were searched for original articles, clinical trials, reviews, and meta-analyses published between 1 January 2000 and 31 March 2020 and pertaining to both the mechanism of action and immunological effects of GC as well as to the …

Pediatricsmedicine.medical_specialtylcsh:RC648-665glucocorticoidsIntravenous methylprednisolonebusiness.industryGraves’ orbitopathyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismReviewthyroid eye diseaseDiseaselcsh:Diseases of the endocrine glands. Clinical endocrinologyintravenous methylprednisolonepharmacology immunologymechanisms of action03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Action (philosophy)030221 ophthalmology & optometrymedicinebusinessTherapeutic Advances in Endocrinology and Metabolism
researchProduct

First Case Report of Primary Carnitine Deficiency Manifested as Intellectual Disability and Autism Spectrum Disorder

2019

Systemic primary carnitine deficiency (PCD) is a genetic disorder caused by decreased or absent organic cation transporter type 2 (OCTN2) carnitine transporter activity, resulting in low serum carnitine levels and decreased carnitine accumulation inside cells. In early life, PCD is usually diagnosed as a metabolic decompensation, presenting as hypoketotic hypoglycemia, Reye syndrome, or sudden infant death; in childhood, PCD presents with skeletal or cardiac myopathy. However, the clinical presentation of PCD characterized by autism spectrum disorder (ASD) with intellectual disability (ID) has seldom been reported in the literature. In this report, we describe the clinical features of a sev…

Pediatricsmedicine.medical_specialtymuscleautismrare diseaseCase ReportSLC22A5lcsh:RC321-57103 medical and health sciences0302 clinical medicineSystemic primary carnitine deficiencymedicineReye SyndromeCarnitineMyopathylcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biology0303 health sciencesbiologybusiness.industryGeneral Neurosciencecarnitinemedicine.diseaseAutism spectrum disorderintellectual disabilitybiology.proteinAutismmedicine.symptombusinessPrimary Carnitine Deficiency030217 neurology & neurosurgerymedicine.drugBrain Sciences
researchProduct

Ocular Refraction at Birth and Its Development During the First Year of Life in a Large Cohort of Babies in a Single Center in Northern Italy

2020

The purpose of this study was to investigate refraction at birth and during the first year of life in a large cohort of babies born in a single center in Northern Italy. We also aimed to analyze refractive errors in relation to the gestational age at birth. An observational ophthalmological assessment was performed within 24 h of birth on 12,427 newborns. Refraction was examined using streak retinoscopy after the administration of tropicamide (1%). Values in the range of between +0.50 ≤ D ≤ +4.00 were defined as physiological refraction at birth. Newborns with refraction values outside of the physiological range were followed up during the first year of life. Comparative analyses were condu…

Pediatricsmedicine.medical_specialtynewbornsgenetic structuresEmmetropiaamblyopia; newborns; physiological refraction; preterm babies; refractive screeningpreterm babieSingle CenterPediatricsnewbornphysiological refractionMedicineRetinoscopyOriginal ResearchAnisometropiaamblyopiamedicine.diagnostic_testrefractive screeningbusiness.industryCongenital myopialcsh:RJ1-570Gestational agelcsh:Pediatricspreterm babiesmedicine.diseaseRefractioneye diseasesPediatrics Perinatology and Child HealthGestationbusinessFrontiers in Pediatrics
researchProduct

Lower eyelid reconstruction by multiple subcutaneous pedicle flaps: a new method.

1992

Abstract In this paper we present an original technique for the reconstruction of the full thickness of the lower eyelid after excision of neoplasms. The method is based on the mobilisation of multiple pedicle subcutaneous flaps outlined in the same eyelid and supported by a chondro-mucosal graft. This technique is used for central and off-central losses which involve the outer rim or up to 75% of the width of the whole eyelid. This method is an alternative to the Hughes (1945), Mustarde´(1981), Tenzel and Stewart (1978) and McGregor (1973) techniques which we have previously used for this type of reconstructive The follow-up is satisfactory in terms of the oncological, functional and aesth…

Pedicle flapmedicine.medical_specialtybusiness.industryEyelidsAnatomyEyelid Neoplasmseye diseasesSurgical FlapsSurgeryNasal Mucosamedicine.anatomical_structureCartilageOtorhinolaryngologyEyelid surgeryConnective TissuemedicineHumansSurgeryFull thicknesssense organsEyelidbusinessSubcutaneous pedicleBritish journal of plastic surgery
researchProduct

Systemic lupus erythematosus and bullous pemphigoid with dramatic response to dapsone

2017

Patient: Female, 11 Final Diagnosis: Bullous pemphigoid in systemic lupus erythematosus Symptoms: Bullous lupus • photosensitive rash • synovitis Medication:— Clinical Procedure: Pharmacological treatment Specialty: Rheumatology Objective: Unusual clinical course Background: Bullous pemphigoid is an autoimmune blistering disease, with relapses, isolated or associated with other autoimmune diseases such as systemic lupus erythematosus (SLE). Joint manifestations rapidly respond to small or moderate doses of corticosteroids, whereas skin manifestations usually respond to antimalarial drugs. Case Report: We describe the clinical case of an 11-year-old girl with SLE. She showed bullous skin les…

Pemphigoidmedicine.medical_specialtyAntimalarials; Child; Dapsone; Female; Humans; Lupus Erythematosus Systemic; Pemphigoid BullousMild proteinuriaArthritisDapsoneAntimalarials030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineSettore MED/38 - Pediatria Generale E SpecialisticaPrednisoneimmune system diseasesPemphigoid BullousmedicineHumansChildskin and connective tissue diseases030203 arthritis & rheumatologyLupus erythematosusintegumentary systembusiness.industryMedicine (all)Dapsone; Lupus erythematosus systemic; Pemphigoid bullous; Medicine (all)ArticlesGeneral Medicinemedicine.diseasePemphigoid bullouDermatologyeye diseasesLupus erythematosus systemicFemaleBullous pemphigoidsense organsbusinessDapsonemedicine.drugPediatric population
researchProduct

Methotrexate as a treatment in ocular cicatricial moderate pemphigoid.

2013

Abstract Clinical case A 73 year-old woman presented with a history of non-specific symptoms and photophobia in both eyes of 1 year progression. The examination revealed a bilateral symblepharon and fornix shortening. Immunohistochemical analysis confirmed the presence of linear deposits of IgG, IgM and C3 along the conjunctival basement membrane. With the diagnosis of ocular cicatricial pemphigoid, systemic treatment with subcutaneous methotrexate was prescribed. Discussion We consider such treatment a very effective initial immunosuppressive alternative in patients with moderate conjunctival inflammation and in cases of rapid progression.

Pemphigoidmedicine.medical_specialtyPhotophobiaEtiologyMetotrexatePemphigoid Benign Mucous MembraneComplications scarHyperemiaBasement MembraneDiagnosis ocular cicatricial pemphigoidmedicineUso terapeuticoHumansOcular cicatricial pemphigoidAgedBasement membraneKeratitisbusiness.industrySymblepharonFornixTherapeutic useDiagnostico penfigoide ocular cicatricialGeneral MedicineComplement C3medicine.diseaseDermatologyeye diseasesAgentes inmunosupresoresmedicine.anatomical_structureMethotrexateImmunoglobulin MEtiologiaImmunoglobulin GEtiologyImmunohistochemistryMethotrexateComplicaciones cicatrizFemalesense organsPenfigoide ocular cicatricialmedicine.symptomImmunosuppressive agentsbusinessConjunctivaImmunosuppressive Agentsmedicine.drugArchivos de la Sociedad Espanola de Oftalmologia
researchProduct